Radical chemoradiotherapy for elderly patients with bladder carcinoma invading muscle

Fernando Arias, Mayte Dueñas, Enrique Martínez, Miguel Angel Domínguez, José Juan Illarramendi, Elena Villafranca, Martín Tejedor, Francisco Molina, Rosa Meiriño, Juan José Valerdi

Producción científica: Contribución a una revistaArtículo en revista científica indexadarevisión exhaustiva

21 Citas (Scopus)


BACKGROUND. Chemoradiotherapy is becoming an alternative to radical cystectomy among patients with bladder carcinoma invading muscle. In 1988, the authors began a protocol with methotrexate, vinblastine, doxorubicin, and cisplatin (M-VAC regimen) and radiotherapy for these patients. Traditionally, age has been considered a determinant factor thereby excluding the older patients from the oncologic protocols that are considered to be more aggressive. The authors analyzed 20 patients (age > 70 years) who were treated during this period with the same protocol as the authors' other patients. METHODS. The study included 20 patients (age range, 70-78 years; median age, 74 years) including 4 patients with T2 disease, 9 with T3 disease, and 7 with T4 disease. All patients had a Karnofsky performance status of > 60. Treatment protocol included cytoreductive transurethral resection, 2 cycles of M-VAC chemotherapy, and radiotherapy (45 grays [Gy] on pelvic volume] with concurrent cisplatin (20 mg/m2 on Days 1-5. Response was determined by cystoscopic evaluation. If there was a complete response, radiotherapy continued until a total dose of 65 Gy; if there was not a complete response, cystectomy was performed. RESULTS. Tumor response after a dose of 45 Gy included 11 complete responses (55%), 5 partial responses (25%), and 4 nonresponses (20%). Overall survival was 75%, 34%, and 27% in the 2nd, 3rd, and 5th years of follow up, respectively. Cause specific survival was 79%, 54%, and 38%, respectively. Survival for patients with complete response was 100%, 60%, and 48%, respectively. Severe toxicity was unconmmon, with the most frequent toxicities being leukopenia and cystitis. No treatment-related death occurred with either treatment protocol. CONCLUSIONS. The age of the individual must not become a strict exclusion criterion for the radical treatment of old patients with invasive bladder carcinoma.

Idioma originalInglés
Páginas (desde-hasta)115-120
Número de páginas6
EstadoPublicada - 1997
Publicado de forma externa


Profundice en los temas de investigación de 'Radical chemoradiotherapy for elderly patients with bladder carcinoma invading muscle'. En conjunto forman una huella única.

Citar esto